著者: MooreAngela, GreenLawrence J, BruceSuzanne, SadickNeil, TschenEduardo, WerschlerPhilip, Cook-BoldenFran E, DhawanSunil S, ForshaDouglass, GoldMichael H, GuenthnerScott, KempersSteven E, KircikLeon H, ParishJennifer L, RendonMarta I, RichPhoebe, Stein-GoldLinda, TyringStephen K, WeissRobert A, NasirAdnan, SchmitzCarsten, BoodhooTerry I, KaoukhovAlexandre, BerkDavid R

原題: Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.

著者: IbrahimHisham, DanishHammad, MorrisseyDavid, DeasyKevin F, McCarthyMairead, DorganJames, FlemingClaire, HowlettCiara, TwohigSarah, VaggTamara, MurphyDesmond M, MaherMichael, PlantBarry J

原題: Individualized approach to elexacaftor/tezacaftor/ivacaftor dosing in cystic fibrosis, in response to self-reported anxiety and neurocognitive adverse events: A case series.

著者: HeoSuyeon, YoungDavid C, SafirsteinJulie, BourqueBrian, AntellMartine H, DiloretoStefanie, RotoloShannon M

原題: Mental status changes during elexacaftor/tezacaftor / ivacaftor therapy.

著者: SpoletiniG, GillgrassL, PollardK, ShawN, WilliamsE, EtheringtonC, CliftonI J, PeckhamD G

原題: Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis.

著者: GrazianoSonia, BoldriniFrancesca, PellicanoGaia Romana, MiloFrancesco, MajoFabio, CristianiLuca, MontemitroEnza, AlghisiFederico, BellaSergio, CutreraRenato, FiocchiAlessandro Giovanni, QuittnerAlexandra, TabariniPaola

原題: Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor: Multidimensional Assessment of Neuropsychological Side Effects and Physical and Mental Health Outcomes in Adolescents and Adults.

著者: GeorgeAshish, SmithBeth, SawickiGregory S, GoetzDanielle M

原題: Survey of patients with cystic fibrosis and caregivers decisions regarding CFTR modulators.

著者: RotoloShannon M, DuehlmeyerStephanie, SlackSarah M, JacobsHollyann R, HeckmanBrian

原題: Testicular pain following initiation of elexacaftor/tezacaftor/ivacaftor in males with cystic fibrosis.

著者: PiehlerLinus, ThalemannRalf, LehmannChristine, TheeStephanie, RöhmelJobst, SyunyaevaZulfiya, StahlMirjam, MallMarcus A, GraeberSimon Y

原題: Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis.

著者: ChengAnn, BakerOlivia, HillUta

原題: Elexacaftor, tezacaftor and ivacaftor: a case of severe rash and approach to desensitisation.

著者: HudsonBrionna N, JacobsHollyann R, PhilbrickAlexander, ZhouXiaolong A, SimonsenMichelle M, SafirsteinJulie A, RotoloShannon M

原題: Drug-induced acne with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.

著者: GavioliElizabeth Marie, GuardadoNerli, HaniffFarah, DeiabNouran, ViderEtty

原題: A current review of the safety of cystic fibrosis transmembrane conductance regulator modulators.

著者: SafirsteinJulie, GrantJonathan J, ClausenEmily, SavantDeepika, DezubeRebecca, HongGina

原題: Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis.

著者: KuekStephanie, McCullaghAngela, PaulEldho, ArmstrongDavid

原題: Real world outcomes of CFTR modulator therapy in Australian adults and children.

著者: BrusaIrene, SondoElvira, PesceEmanuela, TomatiValeria, GioiaDario, FalchiFederico, BalboniBeatrice, Ortega MartínezJose Antonio, VeronesiMarina, RomeoElisa, MargaroliNatasha, RecanatiniMaurizio, GirottoStefania, PedemonteNicoletta, RobertiMarinella, CavalliAndrea

原題: Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5.

著者: LommatzschSherstin T, Taylor-CousarJennifer L

原題: The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy.

著者: YoungDave, BartlettLauren E, GuimbellotJennifer, MilinicTijana, BurdisNora, GillEliana R, LeaseErika D, GossChristopher H, KapnadakSiddhartha G, RamosKathleen J

原題: Patient perspectives on elexacaftor/tezacaftor/ivacaftor after lung transplant.

著者: Carrasco HernándezLaura, Girón MorenoRosa Mª, Balaguer CartagenaMari Nieves, PeláezAdrián, SoleAmparo, Álvarez FernándezAntonio, Felipe MontielAlmudena, OlveiraCasilda, OlveiraGabriel, Gómez BonillaAinhoa, Gómez CrespoBeatriz, García ClementeMarta, Solís GarcíaMarta, Quaresma VázquezJoana, Blitz CastroEnrique, Rodríguez GonzálezJesús, Expósito MarreroAndrea, Diab-CáceresLaila, Ramos HernándezCristina, Zamarrón de LucasEster, Prados SanchezConcha, Blanco AparicioMarina, López NeyraAlejandro, Sanz SantiagoVerónica, Luna ParedesCarmen, Delgado PecellínIsabel, Asensio de la CruzÓscar, Quintana GallegoEsther

原題: Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease.

著者: TümmlerBurkhard

原題: Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-Ivacaftor.

著者: FitzMauriceThomas Simon, NazarethDilip, IyerKapil, WalshawMartin, Al-AloulMohamed

原題: Elexacaftor/Tezacaftor/Ivacaftor as a Bridge to Lung Retransplant in a Recipient With Cystic Fibrosis.

著者: KosRenate, NeerincxAnne H, FennDominic W, BrinkmanPaul, LubRianne, VonkSteffie E M, RoukemaJolt, ReijersMonique H, Terheggen-LagroSuzanne W J, AltenburgJosje, MajoorChristof J, BosLieuwe D, HaarmanEric G, Maitland-van der ZeeAnke H,

原題: Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients.

著者: OrsiniSara Immacolata, MarraniEdoardo, PagniniIlaria, TaccettiGiovanni, TerlizziVito, SimoniniGabriele

原題: Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis.